CZMWF OTC
Carl Zeiss Meditec AG
1W: +2.1%
1M: +4.5%
3M: +27.4%
YTD: -21.2%
1Y: -23.0%
3Y: -54.2%
5Y: -82.1%
$38.21
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$3.4B
+0.3% ▲
5Y CAGR: +11.1%
Total Liabilities
$1.3B
-4.6% ▼
5Y CAGR: +17.8%
Shareholders Equity
$2.1B
+3.7% ▲
5Y CAGR: +8.1%
Cash & Investments
$27M
+34.4% ▲
5Y CAGR: +39.3%
Total Debt
$132M
-12.5% ▼
5Y CAGR: +14.1%
Net Debt
$105M
-19.7% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $7M | $8M | $11M | $20M | $27M |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 |
| Cash & ST Investments | $7M | $8M | $11M | $20M | $27M |
| Net Receivables | $324M | $414M | $421M | $583M | $812M |
| Inventory | $286M | $383M | $520M | $536M | $497M |
| Other Current Assets | $977M | $1.9B | $959M | $68M | -$66M |
| Total Current Assets | $1.6B | $1.8B | $1.9B | $1.2B | $1.3B |
| Property, Plant & Equip. | $200M | $236M | $251M | $354M | $343M |
| Goodwill & Intangibles | $482M | $670M | $429M | $1.7B | $1.9B |
| Long-Term Investments | $24M | $52M | $21M | $20M | $57M |
| Other Non-Current Assets | $785K | $1M | $420M | $31M | -$275M |
| Total Non-Current Assets | $792M | $1.0B | $1.1B | $2.2B | $2.1B |
| Total Assets | $2.4B | $2.8B | $3.0B | $3.4B | $3.4B |
| — Liabilities — | |||||
| Accounts Payable | $145M | $189M | $240M | $184M | $194M |
| Short-Term Debt | -$280M | -$324M | -$294M | $0 | $44M |
| Deferred Revenue | $280M | $324M | $0 | $0 | $0 |
| Other Current Liabilities | $190M | $233M | $488M | $263M | $220M |
| Total Current Liabilities | $448M | $539M | $562M | $569M | $544M |
| Long-Term Debt | $0 | $0 | $0 | $0 | $0 |
| Other Non-Current Liab. | $30M | $0 | $53M | $503M | $491M |
| Total Non-Current Liabilities | $270M | $253M | $298M | $768M | $732M |
| Total Liabilities | $719M | $793M | $860M | $1.3B | $1.3B |
| — Equity — | |||||
| Common Stock | $89M | $89M | $89M | $89M | $89M |
| Retained Earnings | $1.0B | $1.2B | $1.4B | $1.5B | $1.6B |
| Accumulated OCI | -$51M | $92M | $44M | -$4M | -$18M |
| Total Stockholders Equity | $1.7B | $2.0B | $2.2B | $2.0B | $2.1B |
| Total Liabilities & Equity | $2.4B | $2.8B | $3.0B | $3.4B | $3.4B |
| — Key Metrics — | |||||
| Total Debt | $121M | $128M | $156M | $151M | $132M |
| Net Debt | $114M | $120M | $145M | $131M | $105M |
| Total Investments | $24M | $52M | $21M | $20M | $57M |